Menu Search
Equities

Sanai Health Industry Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
WUP0:FRA

Sanai Health Industry Group Co Ltd

Actions
  • Price (EUR)0.043
  • Today's Change0.00 / 0.00%
  • Shares traded352.00
  • 1 Year change+34.38%
  • Beta-0.8651
Data delayed at least 15 minutes, as of Feb 11 2026 09:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sanai Health Industry Group Co Ltd is an investment holding company mainly engaged in pharmaceutical products. The Company operates its business through two segments. Pharmaceutical Products segment is mainly engaged in the development, manufacturing, marketing and sales of pharmaceutical products, sales of pharmaceutical related software and provision of consultancy services. Finance Leasing segment is mainly engaged in provision of finance leasing services.

  • Revenue in HKD (TTM)108.05m
  • Net income in HKD-37.54m
  • Incorporated2006
  • Employees147.00
  • Location
    Sanai Health Industry Group Co LtdRoom 2805 Central PlazaNo.18 Harbour Road, Wanchai Hong KongHKG
  • Phone+852 28276100
  • Fax+852 28276099
  • Websitehttps://www.1889hk.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.